Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - UTAH MEDICAL PRODUCTS INC | exhibit_991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (date of earliest event reported): November 1, 2016
Commission File No. 001-12575
UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)
|
UTAH
|
87‑0342734
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
7043 South 300 West
Midvale, Utah 84047
Address of principal executive offices
Registrant's telephone number: (801) 566‑1200
ITEM 8.01 OTHER EVENTS
On November 1, 2016, Utah Medical Products, Inc. announced that it is increasing its regular quarterly cash dividend. A dividend of $.265 per share is payable on December 30, 2016 to shareholders of record at the close of business on December 16, 2016. A copy of the press release is attached hereto as Exhibit 99.1
ITEM 9.01 EXHIBIS
EXHIBIT INDEX
|
Index
Number
|
Description
|
|
99.1
|
Press release issued November 1, 2016: Utah Medical Products, Inc. Increases Quarterly Dividend
|
|
|
|
SIGNATURES
Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| UTAH MEDICAL PRODUCTS, INC. | |||
| REGISTRANT | |||
|
Date: 11/1/2016
|
By:
|
/s/ Kevin L. Cornwell | |
| Kevin L. Cornwell | |||
| CEO | |||